Drug Target Review

New target found to improve bladder cancer treatment

Explore new findings on bladder cancer and inflammation's role in immune suppression. Discover insights to improve treatment.
CURE

NCCN Guidelines Expand Options for Certain Bladder Cancer Patients

NCCN now includes Anktiva plus BCG for BCG-unresponsive papillary-only NMIBC, acknowledging an unmet need in patients without CIS who have limited post-BCG options. Radical cystectomy remains ...

‘Uresta Stopped My Bladder Leaks After Surgery Failed—My Confidence Is Back!'

For years, Susan Johnstone, 53, lived with an embarrassing problem that threatened to take away the activity she loved most: ...
San Diego Union-Tribune

All the News That’s Fit: Bladder breakthrough, the brainy thumb and iron lungs

In May, surgeons at USC and UCLA collaborated to perform the world’s first-in-human bladder transplant. Currently, when a bladder fails or needs to be removed, doctors create a “neobladder” using a ...
CURE

Anktiva Plus BCG Resubmitted to FDA for Papillary Bladder Cancer

ImmunityBio’s sBLA targets BCG-unresponsive papillary NMIBC without CIS, complementing the existing U.S. approval for CIS ...
Health on MSN

Bladder infection vs. UTI: What's the difference?

Medically reviewed by Cordelia Nwankwo, MD A bladder infection is a type of UTI, but not all UTIs are bladder infections.Seeking medical attention for UTI symptoms can prevent serious complications ...